Vera Bradley Reports First Revenue Growth Since FY22, Significantly Reduces Q1 Operating Loss
VRA has more than doubled off its 52-week low of $1.39 on elevated volume (24× avg).
Summary
Vera Bradley reported its first revenue growth since fiscal 2022, with Q1 net revenues up 7.8% and a 74% reduction in operating loss, driven by improved margins and cost controls.
Key Events · Earnings and Guidance · VRA
-
First Revenue Growth Since FY22
Net revenues increased by 7.8% to $55.7 million for the thirteen weeks ended May 2, 2026, compared to $51.7 million in the prior-year period, marking the first revenue growth since Fiscal 2022.
-
Significant Reduction in Operating Loss
Operating loss from continuing operations decreased by 74% to $(4.6) million, a $13.2 million improvement from $(17.9) million in the comparable prior-year period.
-
Improved Gross Profit and Reduced SG&A
Gross profit increased by 26.6% to $28.8 million, with gross margin improving from 44.1% to 51.8%. Selling, general, and administrative expenses decreased by 16.4% to $34.1 million, reflecting successful cost optimization.
-
Reduced Cash Burn from Operations
Net cash used in operating activities significantly decreased to $(5.3) million, an improvement of $12.6 million compared to $(17.9) million in the prior-year period.
Analysis · VRA · Manufacturing
Vera Bradley, Inc. reported a strong first quarter for fiscal 2027, marking its first revenue growth since fiscal 2022. Net revenues increased by 7.8% to $55.7 million, a significant turnaround from the previous fiscal year's declines. The company also dramatically reduced its operating loss from continuing operations by 74% and net loss by 73.6%. This improvement was driven by a substantial increase in gross profit margin (from 44.1% to 51.8%) and a 16.4% reduction in selling, general, and administrative expenses, reflecting successful cost optimization efforts. These results indicate positive momentum from the company's 'Project Sunshine' strategic initiatives, providing a much-needed boost after a challenging period. An ongoing legal dispute regarding a $4.6 million purchase price adjustment from the Pura Vida sale is noted, but the company is actively disputing the claim.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36% of the 1040 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VRA was trading at $3.45 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $98M. The 52-week trading range was $1.39 to $4.39. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.